246 related articles for article (PubMed ID: 33936057)
1. Decreased Serum 25-(OH)-D Level Associated With Muscle Enzyme and Myositis Specific Autoantibodies in Patients With Idiopathic Inflammatory Myopathy.
Yu Z; Cheng H; Liang Y; Ding T; Yan C; Gao C; Wen H
Front Immunol; 2021; 12():642070. PubMed ID: 33936057
[TBL] [Abstract][Full Text] [Related]
2. Low serum levels of vitamin D in idiopathic inflammatory myopathies.
Azali P; Barbasso Helmers S; Kockum I; Olsson T; Alfredsson L; Charles PJ; Piehl Aulin K; Lundberg IE
Ann Rheum Dis; 2013 Apr; 72(4):512-6. PubMed ID: 22993226
[TBL] [Abstract][Full Text] [Related]
3. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy.
Stone KB; Oddis CV; Fertig N; Katsumata Y; Lucas M; Vogt M; Domsic R; Ascherman DP
Arthritis Rheum; 2007 Sep; 56(9):3125-31. PubMed ID: 17763431
[TBL] [Abstract][Full Text] [Related]
4. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
[TBL] [Abstract][Full Text] [Related]
5. Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review.
Beaton TJ; Gillis D; Prain K; Morwood K; Anderson J; Goddard J; Baird T
Int J Rheum Dis; 2021 Sep; 24(9):1167-1175. PubMed ID: 34250724
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D levels in idiopathic inflammatory myopathy patients: a meta-analysis.
Xiong A; Zhou S; Liu C; Hu Z; Xie C; Zheng X; Luo X
Postgrad Med; 2024 Mar; 136(2):141-149. PubMed ID: 38420733
[TBL] [Abstract][Full Text] [Related]
7. High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis.
Nakajima A; Yoshino K; Soejima M; Kawaguchi Y; Satoh T; Kuwana M; Yamanaka H
Rheumatol Int; 2012 Jul; 32(7):2057-61. PubMed ID: 21479881
[TBL] [Abstract][Full Text] [Related]
8. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Tonello M; Bendo R; Rondinone R; Cozzi F; Doria A
Reumatismo; 2005; 57(1):22-8. PubMed ID: 15776143
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expansion of circulating CD4
Zhang L; Li W; Cai Y; Liu X; Peng Q; Liang L
Int J Rheum Dis; 2020 Mar; 23(3):397-405. PubMed ID: 31883219
[TBL] [Abstract][Full Text] [Related]
10. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy.
Rutjes SA; Vree Egberts WT; Jongen P; Van Den Hoogen F; Pruijn GJ; Van Venrooij WJ
Clin Exp Immunol; 1997 Jul; 109(1):32-40. PubMed ID: 9218821
[TBL] [Abstract][Full Text] [Related]
11. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.
Zampeli E; Venetsanopoulou A; Argyropoulou OD; Mavragani CP; Tektonidou MG; Vlachoyiannopoulos PG; Tzioufas AG; Skopouli FN; Moutsopoulos HM
Clin Rheumatol; 2019 Jan; 38(1):125-132. PubMed ID: 30145635
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.
Aggarwal R; Oddis CV; Goudeau D; Koontz D; Qi Z; Reed AM; Ascherman DP; Levesque MC
Rheumatology (Oxford); 2016 Jun; 55(6):991-9. PubMed ID: 26888854
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies.
Ge Y; Lu X; Peng Q; Shu X; Wang G
PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory Histidyl-Transfer RNA Synthetase-Specific CD4+ T Cells in the Blood and Lungs of Patients With Idiopathic Inflammatory Myopathies.
Galindo-Feria AS; Albrecht I; Fernandes-Cerqueira C; Notarnicola A; James EA; Herrath J; Dastmalchi M; Sandalova T; Rönnblom L; Jakobsson PJ; Fathi M; Achour A; Grunewald J; Malmström V; Lundberg IE
Arthritis Rheumatol; 2020 Jan; 72(1):179-191. PubMed ID: 31403245
[TBL] [Abstract][Full Text] [Related]
15. Impact of vitamin D deficiency on clinical parameters in treatment-naïve rheumatoid arthritis patients.
Liu Y; Wen H
Z Rheumatol; 2018 Nov; 77(9):833-840. PubMed ID: 29460148
[TBL] [Abstract][Full Text] [Related]
16. Myositis-specific autoantibodies in adults with idiopathic inflammatory myopathy: correlations with diagnosis and disease activity.
Zhao L; Su K; Liu T; Sun D; Jiang Z
Clin Rheumatol; 2021 Mar; 40(3):1009-1016. PubMed ID: 32676923
[TBL] [Abstract][Full Text] [Related]
17. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N;
J Autoimmun; 2019 Jul; 101():48-55. PubMed ID: 30992170
[TBL] [Abstract][Full Text] [Related]
18. Differential Clinical Associations of Anti-Nuclear Matrix Protein 2 Autoantibodies in Patients With Idiopathic Inflammatory Myopathies.
Yang H; Lu X; Peng Q; Jiang W; Shi J; Zhang Y; Chen H; Wang G
Arthritis Rheumatol; 2018 Aug; 70(8):1288-1297. PubMed ID: 29534337
[TBL] [Abstract][Full Text] [Related]
19. Clinical contribution of myositis-related antibodies detected by immunoblot to idiopathic inflammatory myositis: A one-year retrospective study.
Lecouffe-Desprets M; Hémont C; Néel A; Toquet C; Masseau A; Hamidou M; Josien R; Martin JC
Autoimmunity; 2018 Mar; 51(2):89-95. PubMed ID: 29463118
[TBL] [Abstract][Full Text] [Related]
20. Ro52/TRIM21-deficient expression and function in different subsets of peripheral blood mononuclear cells is associated with a proinflammatory cytokine response in patients with idiopathic inflammatory myopathies.
Gómez-Martín D; Galindo-Feria AS; Barrera-Vargas A; Merayo-Chalico J; Juárez-Vega G; Torres-Ruiz J; Alcocer-Varela J
Clin Exp Immunol; 2017 Apr; 188(1):154-162. PubMed ID: 27936488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
